Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2026-01-02 @ 10:48 PM
Study NCT ID:
NCT04858256
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2021-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-20
First Submit QC Date:
None
Study First Post Date:
2021-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED